James Vardiman to Myelodysplastic Syndromes
This is a "connection" page, showing publications James Vardiman has written about Myelodysplastic Syndromes.
Connection Strength
5.452
-
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018 03 21; 9(1):1163.
Score: 0.498
-
Acute Myeloid Leukemia With Myelodysplasia-Related Changes. Am J Clin Pathol. 2015 Jul; 144(1):29-43.
Score: 0.412
-
Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome. Leukemia. 2013 Jun; 27(6):1291-300.
Score: 0.350
-
The classification of MDS: from FAB to WHO and beyond. Leuk Res. 2012 Dec; 36(12):1453-8.
Score: 0.339
-
Myelodysplastic/myeloproliferative neoplasms. Semin Diagn Pathol. 2011 Nov; 28(4):283-97.
Score: 0.320
-
Acute myeloid leukemia with expanded erythropoiesis. Haematologica. 2011 Sep; 96(9):1241-3.
Score: 0.316
-
Myelodysplastic syndromes. N Engl J Med. 2009 Nov 05; 361(19):1872-85.
Score: 0.279
-
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact. 2010 Mar 19; 184(1-2):16-20.
Score: 0.278
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51.
Score: 0.268
-
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol. 2007 Feb; 127(2):197-205.
Score: 0.230
-
Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2006; 199-204.
Score: 0.214
-
Myelodysplastic/myeloproliferative diseases. Cancer Treat Res. 2004; 121:13-43.
Score: 0.186
-
Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases. Semin Diagn Pathol. 2003 Aug; 20(3):154-79.
Score: 0.181
-
The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002 Oct 01; 100(7):2292-302.
Score: 0.170
-
Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary. Blood. 2002 Apr 15; 99(8):3074-5.
Score: 0.165
-
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 05 19; 127(20):2391-405.
Score: 0.109
-
Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. Semin Hematol. 1996 Apr; 33(2):111-26.
Score: 0.109
-
Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia. 1996 Jan; 10(1):20-6.
Score: 0.107
-
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica. 2014 May; 99(5):821-9.
Score: 0.093
-
Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am J Clin Pathol. 1993 Apr; 99(4):513-25.
Score: 0.088
-
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood. 1993 Mar 15; 81(6):1580-5.
Score: 0.088
-
Issues in the pathology of the myelodysplastic syndromes. Hematol Oncol Clin North Am. 1992 Jun; 6(3):501-22.
Score: 0.083
-
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009 Nov; 6(11):627-37.
Score: 0.069
-
The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer. 2009 Sep 01; 115(17):3842-7.
Score: 0.069
-
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803). Cancer. 2009 Jan 01; 115(1):84-93.
Score: 0.066
-
Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. Blood. 1988 Oct; 72(4):1333-9.
Score: 0.065
-
Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2004; 297-317.
Score: 0.046
-
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003 Jul 01; 102(1):43-52.
Score: 0.044
-
The new World Health Organization classification of myeloid neoplasms: Q&A with James W. Vardiman, MD. Clin Adv Hematol Oncol. 2003 Jan; 1(1):18, 21.
Score: 0.043
-
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol. 1997 Nov; 99(2):344-51.
Score: 0.030
-
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood. 1993 Aug 01; 82(3):737-43.
Score: 0.023
-
Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia. Blood. 1992 Nov 15; 80(10):2463-70.
Score: 0.021
-
Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood. 1992 Mar 15; 79(6):1501-10.
Score: 0.021
-
t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 1990 Dec 15; 76(12):2594-8.
Score: 0.019
-
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood. 2007 Sep 01; 110(5):1648-55.
Score: 0.015
-
Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 1986 Jun; 67(6):1765-72.
Score: 0.014
-
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar; 4(3):325-45.
Score: 0.013
-
Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Ann Hematol. 2004 Aug; 83(8):513-21.
Score: 0.012